Cite Filings / MPLT / 0001193125-26-191518
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEFA14A

Proxy Materials

MapLight Therapeutics, Inc. · Filed 2026-04-29 · Acc 0001193125-26-191518

Documents 1

  • DEFA14A Proxy Materials , d40572ddefa14a.htm

Around this filing

  • 2026-04-29 4 Chief Discovery Officer sold 45,422 shares at an average $29.66 ($1,347,066)
  • 2026-04-29 4 CAAO and PAO sold 69,835 shares at an average $29.89 ($2,087,687)
  • 2026-04-29 8-K Executive or director change
  • 2026-04-29 ARS Annual Report to Security Holders
  • 2026-04-29 DEFA14A Proxy Materials
  • 2026-04-29 DEF 14A Proxy Statement
  • 2026-04-27 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d40572ddefa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…